Alliance Pharma plc (AIM:APH)
London
· Delayed Price · Currency is GBP · Price in GBX 64.60
+0.20 (0.31%)
Apr 25, 2025, 5:15 PM GMT+1
Alliance Pharma Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -10.73 | -33.14 | -21.21 | 7.32 | 8.03 | Upgrade
|
| Depreciation & Amortization | 7.79 | 8.42 | 8.8 | 8.74 | 8.91 | Upgrade
|
| Other Amortization | 2.23 | 2.36 | 2.61 | 2 | 0.58 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.4 | - | - | - | 0.31 | Upgrade
|
| Asset Writedown & Restructuring Costs | 36.51 | 79.25 | 46.49 | 6.15 | 12.06 | Upgrade
|
| Stock-Based Compensation | 1.65 | 0.89 | 0.09 | 2.25 | 1.37 | Upgrade
|
| Other Operating Activities | -0.24 | -12.19 | -1.09 | 7.36 | 2.86 | Upgrade
|
| Change in Accounts Receivable | 5.42 | -6.48 | -18.72 | -6.15 | 6.73 | Upgrade
|
| Change in Inventory | 3.11 | -1.86 | -2.21 | 1.84 | -5.21 | Upgrade
|
| Change in Accounts Payable | -4.97 | 1.94 | 7.28 | -0.33 | 5.93 | Upgrade
|
| Change in Other Net Operating Assets | 0.34 | -7.79 | -1.08 | 9.47 | - | Upgrade
|
| Operating Cash Flow | 38.72 | 31.41 | 20.97 | 38.66 | 41.57 | Upgrade
|
| Operating Cash Flow Growth | 23.26% | 49.77% | -45.75% | -7.00% | 16.25% | Upgrade
|
| Capital Expenditures | -0.84 | -0.7 | -0.36 | -1.53 | -4.61 | Upgrade
|
| Cash Acquisitions | - | -0.22 | -16.62 | 0.18 | -82.67 | Upgrade
|
| Sale (Purchase) of Intangibles | 2.84 | - | -0.25 | -3.26 | 1.41 | Upgrade
|
| Other Investing Activities | 0.06 | - | 0.2 | - | 0.01 | Upgrade
|
| Investing Cash Flow | 2.06 | -0.92 | -17.03 | -4.6 | -85.86 | Upgrade
|
| Long-Term Debt Issued | - | - | 14.93 | - | 82.6 | Upgrade
|
| Long-Term Debt Repaid | -22.09 | -18.87 | -2.22 | -23.51 | -22.43 | Upgrade
|
| Net Debt Issued (Repaid) | -22.09 | -18.87 | 12.7 | -23.51 | 60.17 | Upgrade
|
| Issuance of Common Stock | 0.02 | 0.04 | 0.34 | 0.74 | 1.64 | Upgrade
|
| Common Dividends Paid | - | -9.59 | -9.12 | -8.6 | -2.84 | Upgrade
|
| Other Financing Activities | -8.82 | -10.77 | -4.8 | -2.97 | -3.23 | Upgrade
|
| Financing Cash Flow | -30.88 | -39.19 | -0.88 | -34.34 | 55.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.04 | -0.58 | -0.42 | 0.45 | -0.38 | Upgrade
|
| Net Cash Flow | 9.92 | -9.28 | 2.65 | 0.16 | 11.07 | Upgrade
|
| Free Cash Flow | 37.88 | 30.71 | 20.61 | 37.13 | 36.96 | Upgrade
|
| Free Cash Flow Growth | 23.32% | 49.00% | -44.49% | 0.48% | 16.90% | Upgrade
|
| Free Cash Flow Margin | 21.18% | 17.00% | 12.31% | 22.75% | 28.47% | Upgrade
|
| Free Cash Flow Per Share | 0.07 | 0.06 | 0.04 | 0.07 | 0.07 | Upgrade
|
| Cash Interest Paid | 8.8 | 9.43 | 4.8 | 2.97 | 2.87 | Upgrade
|
| Cash Income Tax Paid | 5.58 | 5.52 | 3.96 | 6.26 | 4.84 | Upgrade
|
| Levered Free Cash Flow | 32.08 | 16.84 | 9.75 | 37.26 | 29.5 | Upgrade
|
| Unlevered Free Cash Flow | 37.35 | 22.62 | 12.5 | 38.9 | 30.57 | Upgrade
|
| Change in Net Working Capital | -5.98 | 14.5 | 15.52 | -7.28 | -4.95 | Upgrade
|
Updated Sep 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.